OSI Systems, Inc. Form 10-K Summary
Business context and reporting period
This Form 10-K covers the fiscal year ended June 30, 2014, not calendar-year 2013 Q4. OSI Systems designs and manufactures specialized electronic systems and components through three divisions: Security, Healthcare, and Optoelectronics and Manufacturing. The company serves homeland security, healthcare, defense, aerospace, industrial and other markets.
- Security revenue: $440.4 million, approximately 49% of consolidated revenue.
- Healthcare revenue: $222.3 million, approximately 24%.
- Optoelectronics and Manufacturing third-party revenue: $244.0 million, approximately 27%.
- International shipments represented approximately 61% of revenue, up from 52% in fiscal 2013.
Financial performance and key metrics
| Metric | Fiscal 2014 | Fiscal 2013 | Change |
|---|---|---|---|
| Revenue | $906.7 million | $802.0 million | Up 13% |
| Gross profit | $305.0 million | $290.4 million | Up 5% |
| Gross margin | 33.6% | 36.2% | Down 2.6 points |
| Operating income | $81.3 million | $74.4 million | Up 9% |
| Net income | $47.9 million | $44.1 million | Up 9% |
| Diluted EPS | $2.33 | $2.15 | Up 8% |
| Cash flow from operations | $129.2 million | $58.7 million | Up 120% |
| Capital expenditures | $54.6 million | $157.4 million | Down 65% |
| Cash and equivalents | $38.8 million | $34.7 million | Up 12% |
| Total debt | $37.3 million | $71.5 million | Down $34.2 million |
Operating expenses were $223.7 million, including $166.9 million of selling, general and administrative expense, $44.8 million of research and development expense, and $12.0 million of impairment, restructuring and other charges. The effective tax rate was 36.9%; excluding a $7.6 million non-cash tax charge related to accelerated depreciation elections in Mexico, management stated that the effective rate would have been approximately 26.8%.
Working capital increased to $269.3 million from $244.9 million. Inventories increased to $234.1 million from $206.2 million, while net accounts receivable declined to $185.8 million from $206.8 million. Total assets were $1.024 billion and stockholders’ equity was $532.2 million at June 30, 2014.
Material changes versus the prior comparable period
- Security revenue increased 18% to $440.4 million, driven primarily by a $52.0 million increase in Mexican turnkey screening services and a $33.5 million increase in cargo equipment revenue, including partial fulfillment of a U.S. Department of Defense foreign military sale. Baggage and parcel inspection revenue declined $20.2 million.
- Healthcare revenue declined 4% to $222.3 million, primarily because patient monitoring sales decreased $8.7 million as North American hospitals delayed capital spending.
- Optoelectronics and Manufacturing revenue increased 23% to $244.0 million. Acquisitions contributed $28.0 million, while organic growth contributed $17.5 million, led by contract manufacturing.
- Gross margin declined because lower-margin Optoelectronics and Manufacturing revenue grew faster, contract manufacturing represented a larger mix, Healthcare revenue declined, and depreciation increased as Mexican turnkey operations ramped up.
- Operating income improved despite higher SG&A and $12.0 million of impairment, restructuring and other charges, including $5.8 million related to U.S. government contract issues, $2.0 million for Healthcare facility relocation, $1.3 million of debt restructuring costs and $0.6 million of securities class-action defense costs.
- Cash flow benefited from improved collections, including receivables related to the Mexican turnkey program, and higher deferred revenue. The company repaid $35.0 million of bank-line borrowings and repurchased $20.6 million of common stock, including tax withholding related to equity awards.
- Backlog declined to approximately $0.8 billion from $1.0 billion, primarily as revenue was recognized from the large Mexican turnkey program.
Liquidity, debt and commitments
- The company had a $450 million revolving credit facility maturing in May 2019, with a $375 million letter-of-credit sub-limit and $24.0 million outstanding at June 30, 2014.
- Letters of credit outstanding totaled $102.9 million; total other commercial commitments for letters of credit were reported at $124.7 million.
- Long-term debt was $13.3 million, including an $8.5 million balance on the Washington facility term loan. Total debt maturities were $37.3 million, including $26.8 million due within one year.
- Approximately 83% of cash and cash equivalents were held by foreign subsidiaries and subject to repatriation tax considerations.
- Management stated that available funds, credit facilities and operating cash flow should be sufficient for foreseeable operational needs, subject to acquisitions, capital expenditures, litigation, stock repurchases, covenant compliance and capital-market conditions.
- The company had no off-balance-sheet arrangements as defined by Regulation S-K other than disclosed commitments.
Outlook, commentary, risks and unusual items
- Management expects continued investment in product development, international operations, vertical integration and selective acquisitions, but the filing provides no quantitative fiscal 2015 revenue or earnings guidance.
- The TSA terminated a delivery order for default after the Security division used an upgraded X-ray generator without obtaining required advance TSA approval. The component was subsequently approved, but DHS review remained unresolved and could result in restrictions on future U.S. government business.
- An August 2014 FDA warning letter addressed procedures and internal processes at the Healthcare facility in Snoqualmie, Washington. The company stated that production and shipments were not restricted, but additional regulatory action, including injunctions, recalls, fines or operating restrictions, remained possible.
- The company is defending a putative securities class action and a related shareholder derivative action concerning alleged disclosures about Rapiscan automated threat-recognition software and use of unapproved parts. Outcomes and potential losses were not reasonably estimable.
- The Government of Albania halted further progress on a 15-year turnkey cargo and vehicle screening contract; OSI Systems began proceedings to protect its legal rights.
- The company is investigating historical soil and groundwater contamination at its Hawthorne, California facility. No environmental loss contingency was accrued because management considered any unfavorable outcome not probable and reasonably estimable.
- Key operating risks include government budget reductions and sequestration, lengthy procurement cycles, contract termination rights, regulatory compliance, product liability, medical-device recalls, competition, foreign exchange, international operations, cybersecurity, single-source suppliers, excess inventory and acquisition integration.
- Foreign-currency sensitivity was significant: management estimated that a 10% appreciation or depreciation of the U.S. dollar against local currencies would have changed fiscal 2014 operating income by approximately $12.0 million in the opposite direction.
Investor verification checklist
- Verify the filing period: fiscal year ended June 30, 2014, rather than a calendar 2013 fourth quarter.
- Assess the sustainability and margin impact of Mexican turnkey screening revenue and the remaining $75.0 million customer advance.
- Review the TSA/DHS compliance matter, Administrative Agreement, termination-for-default consequences and related accrued charges.
- Monitor the FDA warning letter, corrective actions and any subsequent enforcement, recall or operating restrictions.
- Reconcile backlog conversion, backlog decline and the concentration of revenue and assets related to Mexico and government customers.
- Evaluate liquidity after considering $24.0 million of revolving debt, $102.9 million of letters of credit, near-term debt maturities and foreign-held cash.
- Review the securities class action, derivative action, Albania contract dispute and Hawthorne environmental investigation for potential future cash costs or liabilities.
- Confirm the effect of the lower-margin contract manufacturing mix, higher inventory and elevated depreciation on future gross margins and cash conversion.